Home
Oncology Intermediates
Lenalidomide Intermediates (3-Aminopiperidine-2,6-dione HCl & Methyl 2-Bromomethyl-3-nitrobenzoate)
CAS # 24666-56-6 / 98475-07-1
Pharma Synthesis Grade
Lenalidomide Intermediates (3-Aminopiperidine-2,6-dione HCl & Methyl 2-Bromomethyl-3-nitrobenzoate)
Pharmabridge supplies key synthetic intermediates for Lenalidomide immunomodulatory oncology API synthesis: 3-Aminopiperidine-2,6-dione HCl (CAS 24666-56-6) and Methyl 2-(bromomethyl)-3-nitrobenzoate (CAS 98475-07-1).
Assay / Purity
≥ 98.5%
Physical Appearance
Crystalline Powder
Documentation
CoA / DMF / GMP
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Chemical / Product Name
Lenalidomide Intermediates (3-Aminopiperidine-2,6-dione HCl & Methyl 2-Bromomethyl-3-nitrobenzoate)
CAS Registry Number
24666-56-6 / 98475-07-1
Standard Grade
Pharma Synthesis Grade
Assay / Purity
≥ 98.5%
Appearance
Crystalline Powder
Formulation & Industry Applications
Lenalidomide API Synthesis
Process Development & Scale-up
Related Ingredients
Explore complementary ingredients in Oncology Intermediates: